LRCX vs. LLY
Compare and contrast key facts about Lam Research Corporation (LRCX) and Eli Lilly and Company (LLY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: LRCX or LLY.
Correlation
The correlation between LRCX and LLY is 0.49, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
LRCX vs. LLY - Performance Comparison
Key characteristics
LRCX:
-0.31
LLY:
-0.11
LRCX:
-0.14
LLY:
0.08
LRCX:
0.98
LLY:
1.01
LRCX:
-0.36
LLY:
-0.20
LRCX:
-0.59
LLY:
-0.40
LRCX:
28.38%
LLY:
12.45%
LRCX:
51.74%
LLY:
38.01%
LRCX:
-87.91%
LLY:
-68.27%
LRCX:
-32.54%
LLY:
-23.23%
Fundamentals
LRCX:
$95.32B
LLY:
$737.66B
LRCX:
$3.59
LLY:
$12.27
LRCX:
20.76
LLY:
66.95
LRCX:
1.10
LLY:
1.33
LRCX:
5.56
LLY:
15.05
LRCX:
10.02
LLY:
46.91
LRCX:
$17.14B
LLY:
$49.00B
LRCX:
$8.24B
LLY:
$40.03B
LRCX:
$5.83B
LLY:
$16.67B
Returns By Period
In the year-to-date period, LRCX achieves a 4.65% return, which is significantly higher than LLY's -4.68% return. Both investments have delivered pretty close results over the past 10 years, with LRCX having a 27.59% annualized return and LLY not far ahead at 28.50%.
LRCX
4.65%
5.98%
-3.04%
-16.05%
24.74%
27.59%
LLY
-4.68%
-2.54%
-11.36%
-4.17%
38.56%
28.50%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
LRCX vs. LLY — Risk-Adjusted Performance Rank
LRCX
LLY
LRCX vs. LLY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Lam Research Corporation (LRCX) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
LRCX vs. LLY - Dividend Comparison
LRCX's dividend yield for the trailing twelve months is around 1.18%, more than LLY's 0.74% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LRCX Lam Research Corporation | 1.18% | 1.19% | 0.95% | 1.53% | 0.78% | 1.04% | 1.54% | 2.79% | 1.01% | 1.28% | 1.36% | 0.68% |
LLY Eli Lilly and Company | 0.74% | 0.67% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.95% | 2.46% | 2.77% | 2.37% | 2.84% |
Drawdowns
LRCX vs. LLY - Drawdown Comparison
The maximum LRCX drawdown since its inception was -87.91%, which is greater than LLY's maximum drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for LRCX and LLY. For additional features, visit the drawdowns tool.
Volatility
LRCX vs. LLY - Volatility Comparison
The current volatility for Lam Research Corporation (LRCX) is 13.46%, while Eli Lilly and Company (LLY) has a volatility of 22.18%. This indicates that LRCX experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
LRCX vs. LLY - Financials Comparison
This section allows you to compare key financial metrics between Lam Research Corporation and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
LRCX vs. LLY - Profitability Comparison
LRCX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Lam Research Corporation reported a gross profit of 2.31B and revenue of 4.72B. Therefore, the gross margin over that period was 49.0%.
LLY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a gross profit of 10.50B and revenue of 12.73B. Therefore, the gross margin over that period was 82.5%.
LRCX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Lam Research Corporation reported an operating income of 1.56B and revenue of 4.72B, resulting in an operating margin of 33.1%.
LLY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported an operating income of 5.41B and revenue of 12.73B, resulting in an operating margin of 42.5%.
LRCX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Lam Research Corporation reported a net income of 1.33B and revenue of 4.72B, resulting in a net margin of 28.2%.
LLY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a net income of 2.76B and revenue of 12.73B, resulting in a net margin of 21.7%.